Abstract
India's pharmaceutical sector is currently undergoing unprecedented change. India ratified the agreement establishing the World Trade Organization (WTO). This Agreement, inter-alia, contains an Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) which lays down minimum standards for protection and enforcement of IPR which are required to promote effective and adequate protection of IPR with a view to reducing distortions. Much of this is due to the country's introduction, on January 1, 2005, of a system of product patents; before that, only patents for processes were permitted to be issued. The purpose of this research paper is to study the problems faced by innover in filling patent in Indian pharmaceutical industry. The paper also includes study of problem related to research and development activities, patent filling process etc.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
